Sabtu, 01 Januari 2022

Is it safe to invest in biotech stocks again?

MarketBeat - Empowering Individual Investors to Make Better Trading Decisions

Hey there - 

Biotech stocks were among the biggest pandemic winners. Many companies saw their stock triple or quadruple in value even if they were a pre-revenue company.

However, early in 2021, the biotech bubble burst, and many retail investors have fled the sector in search of better prospects. And I suspect that there was more than a little virus fatigue as well.

For example, one of the most popular ETFs, the VanEck Vectors Biotech ETF is down more than 15% for the year. So you can imagine what it’s been like for many individual biotech stocks. If you’re a buy-and-hold investor, you may be licking some wounds.

But it’s looking like a good time to take a close look at biotech stocks, and not just the companies that are producing Covid-19 vaccines. Biotechnology is a diverse field that runs the gamut from vaccines and therapeutics to gene-editing technology that has the potential to create a paradigm change in how we deal with diseases such as diabetes and cancer.

And investors who knew what companies to buy have done well. Many of those names will continue to lead the biotech sector in 2022. In this special presentation, we give investors seven biotech stocks that represent different aspects of this diverse sector. We’re confident there’s something for investors of all risk tolerances.

View the first company.

Matthew Paulson
MarketBeat.com


Thank you for subscribing to MarketBeat!

We empower individual investors to make better trading decisions by providing real-time financial information and objective market research.

MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!).

If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.

If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.

© 2006-2022 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Smart, Low-Risk Investing For Retirementpixel

Tidak ada komentar:

Posting Komentar